What is the use of carbopplatin and etoposide?
The use of carbopplatin and etoposide should treat different types of cancer either in combination with another drug or separately. Both drugs are considered to be the treatment of small cell lung cancer and are given in combination to treat the condition. Patients receive intravenous dripping of both drugs on the first day of treatment, then etoposide is administered in the second and third days intravenously or as oral capsules. Ethoposide can independently treat lung cancer with small cells, ovarian cancer, some leukemia and testicular cancer. Carbopplatin can be used separately to treat ovarian cancer, lung cancer with small cells, testicular cancer and some bladder cancer. This means that therapy is one of the most effective treatment of the condition. It is unlikely that carbopplatin and etoposide are offered together for another condition. Doctors like to use combined therapy to treat cancer because different drugs attack cancer cells in different ways and at different stages of the cell life cycle.
treatment with carbopplatin and etoposide occurs in 21 -day cycles, with the first three days used for treatment. The first day consists of intravenous administration of both drugs, while carbopplatin is administered after 30 minutes to an hour and etoposide administered after an hour. Carbopplatin is mixed in glucose solution and etoposide is mixed in sodium chloride solution (salt). The second and third days of treatment consist of further dosing of etoposide. This can be re -served as intravenous drip or as oral tablets.
carbopplatin is a platinum -based chemotherapy suitable for use without etoposide. The medicine works by stopping cancer cells in the repair of itself, which eventually leads to cell dying. It is approved for use in cases of lung cancer without cells and ovarian cancer by the United States and medicinal administration. Other uses-bike uses outside the designation-prescribed doctors include treatment of testicles, stomach and bladder. WhoBinace carbopplatin and etoposide is the only way the drug is used in the treatment of lung cancer with small cells.
Etoposide is also a chemotherapeutic drug also suitable for use without a combination with carbopplatin. The drug slows the growth of cancer cells, stopping the progression of the condition. It is primarily used to treat lung cancer with small cells, but can also be used outside the brand for ovarian cancer, testicular cancer and prostate cancer. Although the combination of carbopplatin and etoposide for the treatment of small cell lung cancer is common, etoposide can also be used separately to treat the condition.